Department of Chemical Engineering, Northeastern University, 360 Huntington Avenue, 223 Cullinane, Boston, MA 02115, USA.
J Ind Microbiol Biotechnol. 2022 Oct 13;49(5). doi: 10.1093/jimb/kuac019.
Acetogenic bacteria are an increasingly popular choice for producing fuels and chemicals from single carbon (C1) substrates. Eubacterium limosum is a promising acetogen with several native advantages, including the ability to catabolize a wide repertoire of C1 feedstocks and the ability to grow well on agar plates. However, despite its promise as a strain for synthetic biology and metabolic engineering, there are insufficient engineering tools and molecular biology knowledge to leverage its native strengths for these applications. To capitalize on the natural advantages of this organism, here we extended its limited engineering toolbox. We evaluated the copy number of three common plasmid origins of replication and devised a method of controlling copy number and heterologous gene expression level by modulating antibiotic concentration. We further quantitatively assessed the strength and regulatory tightness of a panel of promoters, developing a series of well-characterized vectors for gene expression at varying levels. In addition, we developed a black/white colorimetric genetic reporter assay and leveraged the high oxygen tolerance of E. limosum to develop a simple and rapid transformation protocol that enables benchtop transformation. Finally, we developed two new antibiotic selection markers-doubling the number available for this organism. These developments will enable enhanced metabolic engineering and synthetic biology work with E. limosum.
产乙酸菌是一种越来越受欢迎的选择,可将单碳 (C1) 底物转化为燃料和化学品。Eubacterium limosum 是一种很有前途的产乙酸菌,具有多种天然优势,包括能够代谢广泛的 C1 饲料和在琼脂平板上良好生长的能力。然而,尽管它有望成为合成生物学和代谢工程的菌株,但缺乏足够的工程工具和分子生物学知识来利用其天然优势来实现这些应用。为了利用该生物体的天然优势,我们扩展了其有限的工程工具包。我们评估了三种常见质粒复制原点的拷贝数,并设计了一种通过调节抗生素浓度来控制拷贝数和异源基因表达水平的方法。我们进一步定量评估了一系列启动子的强度和调控紧密度,开发了一系列用于不同水平基因表达的经过良好表征的载体。此外,我们开发了一种黑色/白色比色遗传报告基因测定法,并利用 E. limosum 的高耐氧性开发了一种简单快速的转化方案,可实现台式转化。最后,我们开发了两种新的抗生素选择标记物——使该生物体可用的标记物数量增加了一倍。这些发展将使 E. limosum 的代谢工程和合成生物学工作得到增强。